Reported Standalone quarterly numbers for OXYGENTA PHARMACEUTICAL are:Net Sales at Rs 6.06 crore in September 2022 down 60.89% from Rs. 15.49 crore in September 2021.
Quarterly Net Loss at Rs. 2.34 crore in September 2022 down 502.01% from Rs. 0.39 crore in September 2021.
EBITDA stands negative at Rs. 1.50 crore in September 2022 down 232.74% from Rs. 1.13 crore in September 2021.
OXYGENTA PHARMA shares closed at 26.15 on November 14, 2022 (BSE) and has given 13.45% returns over the last 6 months and -9.83% over the last 12 months.
| OXYGENTA PHARMACEUTICAL | | Standalone Quarterly Results | in Rs. Cr. |
|
| Sep'22 | Jun'22 | Sep'21 | | Net Sales/Income from operations | 6.06 | 8.89 | 15.49 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 6.06 | 8.89 | 15.49 | | EXPENDITURE | | Consumption of Raw Materials | 5.05 | 7.61 | 7.68 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -1.13 | -0.77 | 3.86 | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.29 | 0.14 | 0.07 | | Depreciation | 0.40 | 0.40 | 0.40 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 3.35 | 2.96 | 2.74 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -1.90 | -1.45 | 0.73 | | Other Income | -- | -- | 0.00 | | P/L Before Int., Excpt. Items & Tax | -1.90 | -1.45 | 0.73 | | Interest | 0.10 | 0.25 | 0.30 | | P/L Before Exceptional Items & Tax | -2.00 | -1.69 | 0.42 | | Exceptional Items | -0.34 | -- | -0.81 | | P/L Before Tax | -2.34 | -1.69 | -0.39 | | Tax | -- | -- | -- | | P/L After Tax from Ordinary Activities | -2.34 | -1.69 | -0.39 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -2.34 | -1.69 | -0.39 | | Equity Share Capital | 14.20 | 14.20 | 14.20 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -1.64 | -1.19 | -0.27 | | Diluted EPS | -1.64 | -1.19 | -0.27 | | EPS After Extra Ordinary | | Basic EPS | -1.64 | -1.19 | -0.27 | | Diluted EPS | -1.64 | -1.19 | -0.27 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|